Dextroamphetamine is commonly used to treat ADHD, and recent evidence suggests that this medication may decrease drug use in individuals dependent on cocaine. Thus, the present pilot study will determine the ability of dextroamphetamine to treat individuals with both cocaine dependence and ADHD.
This double-blind, placebo-controlled pilot study will determine the ability of dextroamphetamine to treat comorbid cocaine dependence and ADHD. Participants will be randomly assigned on receive placebo or Dextroamphetamine SR (60 mg/day) during a 12-week study period. All participants will receive weekly cognitive behavioral therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
5
matched placebo
60 mg/day
University of Texas Health Science Center
Houston, Texas, United States
Substance use
Time frame: Duration of study
ADHD symptoms
Time frame: Duration of study
Treatment retention
Time frame: Duration of study
Cocaine craving
Time frame: Duration of study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.